FGFR2 and lung carcinoma: To our knowledge, this is the first study to investigate an entire profile of both the best known as well as novel driver genes, such as PTEN, DDR2, and FGFR2, in NSCLC patients, while taking into account different histologic types and smoking status in Chinese lung cancer patients.